Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000436122 | SCV000511009 | likely benign | not provided | 2017-02-06 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Ambry Genetics | RCV002318374 | SCV000850609 | likely benign | Inborn genetic diseases | 2017-04-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001078483 | SCV001018465 | likely benign | KBG syndrome | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000436122 | SCV001825441 | likely benign | not provided | 2021-02-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000436122 | SCV003917859 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | ANKRD11: BP4, BS1 |
Prevention |
RCV003922689 | SCV004738743 | likely benign | ANKRD11-related condition | 2021-01-20 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |